Tag: Herriot Tabuteau

Axsome Therapeutics to acquire Sunosi from Jazz Pharmaceuticals

Axsome Therapeutics has agreed to acquire Sunosi (solriamfetol), an approved dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI), from Jazz Pharmaceuticals. Sunosi is indicated to improve ... Read More